141 related articles for article (PubMed ID: 16584150)
1. Artemisia arborescens L essential oil-loaded solid lipid nanoparticles for potential agricultural application: preparation and characterization.
Lai F; Wissing SA; Müller RH; Fadda AM
AAPS PharmSciTech; 2006 Jan; 7(1):E2. PubMed ID: 16584150
[TBL] [Abstract][Full Text] [Related]
2. Artemisia arborescens L essential oil-loaded solid lipid nanoparticles for potential agricultural application: Preparation and characterization.
Lai F; Wissing SA; Müller RH; Fadda AM
AAPS PharmSciTech; 2006 Mar; 7(1):E10. PubMed ID: 28290017
[TBL] [Abstract][Full Text] [Related]
3. SLN as a topical delivery system for Artemisia arborescens essential oil: in vitro antiviral activity and skin permeation study.
Lai F; Sinico C; De Logu A; Zaru M; Müller RH; Fadda AM
Int J Nanomedicine; 2007; 2(3):419-25. PubMed ID: 18019840
[TBL] [Abstract][Full Text] [Related]
4. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
Venkateswarlu V; Manjunath K
J Control Release; 2004 Mar; 95(3):627-38. PubMed ID: 15023472
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil.
Shi F; Zhao JH; Liu Y; Wang Z; Zhang YT; Feng NP
Int J Nanomedicine; 2012; 7():2033-43. PubMed ID: 22619540
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application.
Paranjpe M; Finke JH; Richter C; Gothsch T; Kwade A; Büttgenbach S; Müller-Goymann CC
Int J Pharm; 2014 Dec; 476(1-2):41-9. PubMed ID: 25261709
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
[TBL] [Abstract][Full Text] [Related]
11. Characterization and stability of nanostructured lipid carriers as drug delivery system.
Abbasalipourkabir R; Salehzadeh A; Abdullah R
Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
[TBL] [Abstract][Full Text] [Related]
12. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
13. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles carrying Eugenia caryophyllata essential oil: the novel nanoparticulate systems with broad-spectrum antimicrobial activity.
Fazly Bazzaz BS; Khameneh B; Namazi N; Iranshahi M; Davoodi D; Golmohammadzadeh S
Lett Appl Microbiol; 2018 Jun; 66(6):506-513. PubMed ID: 29569372
[TBL] [Abstract][Full Text] [Related]
15. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN).
Souto EB; Anselmi C; Centini M; Müller RH
Int J Pharm; 2005 May; 295(1-2):261-8. PubMed ID: 15848010
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate.
Uner M; Wissing SA; Yener G; Müller RH
Pharmazie; 2005 Aug; 60(8):577-82. PubMed ID: 16124399
[TBL] [Abstract][Full Text] [Related]
18. Liposomal incorporation of Artemisia arborescens L. essential oil and in vitro antiviral activity.
Sinico C; De Logu A; Lai F; Valenti D; Manconi M; Loy G; Bonsignore L; Fadda AM
Eur J Pharm Biopharm; 2005 Jan; 59(1):161-8. PubMed ID: 15567314
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles as a delivery system for Zataria multiflora essential oil: formulation and characterization.
Moghimipour E; Ramezani Z; Handali S
Curr Drug Deliv; 2013 Apr; 10(2):151-7. PubMed ID: 23432388
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound.
Silva AC; González-Mira E; García ML; Egea MA; Fonseca J; Silva R; Santos D; Souto EB; Ferreira D
Colloids Surf B Biointerfaces; 2011 Aug; 86(1):158-65. PubMed ID: 21530187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
